Human Gene Therapy

Human Gene Therapy Methods

Human Gene Therapy Clinical Development

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editors, Europe: Nathalie Cartier, MD and Thierry VandenDriessche, PhD
Deputy Editors, U.S.: Barry J. Byrne, MD, PhD and Mark A. Kay, MD, PhD
Human Gene Therapy Editor: Guangping Gao, PhD
Methods Editor: Hildegard Büning, PhD
Clinical Development Editor: James M. Wilson, MD, PhD

ISSN: 1043-0342 | Online ISSN: 1557-7422 | Published 22 issues annually | Current Volume: 30

Latest Impact Factor* is 4.241
*2017 Journal Citation Reports® (Clarivate Analytics, 2018)

The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies. View Aims & Scope…

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts Submit a Paper Share with a Colleague

Announcements

Human Gene Therapy Methods Latest Impact Factor* 1.831
Human Gene Therapy Clinical Development Latest Impact Factor* 2.490

Submit to Your Manuscript: Special Issue on Manufacturing and Quality Controll

Sign Up for Our Free eNewsletter: Gene and Cell Therapy Connect

Read Now: Consensus Statement of European Societies of Gene and Cell Therapy on the Reported Birth of Genome-Edited Babies in China

Featured Content

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.